[Pharmacologic prevention of allergic complications caused by local anesthesia in odontostomatology].
The immunological responses of IgE mediated Type I and of cell-mediated Type IV that intervene in the biphasic mechanism of allergic phenomena, represent the site of action of the pharmacological therapeutic aids usable in the prophylaxis of allergic complications of local anaesthetics. Having examined the pharmacodynamics, the possible clinical use of these drugs is discussed.
Moniaci
D
D
Mozzati
M
M
Albera
G
G
Parabita
S F
SF
Re
G
G
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000009:adverse effects*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D006969:Hypersensitivity, Immediate / Q000139:chemically induced; D007665:Ketotifen / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D004205:Cromolyn Sodium; D007665:Ketotifen
Prevenzione farmacologica delle complicanze allergiche da anestesia locale in odontostomatologia.